Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Myeloid 4Dermatologic 4

Conditions

Breast Neoplasms 10180Neoplasms 7807Carcinoma, Non-Small-Cell Lung 5756Prostatic Neoplasms 5024Colorectal Neoplasms 4603Lung Neoplasms 3723Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3082Multiple Myeloma 3081Pancreatic Neoplasms 2843Melanoma 2651Ovarian Neoplasms 2573Lymphoma 2570Carcinoma, Hepatocellular 2479Stomach Neoplasms 2329Recurrence 2229Head and Neck Neoplasms 2102Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2057Leukemia 2013Brain Neoplasms 1902Glioblastoma 1795Colonic Neoplasms 1790Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1719Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1651Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

trolamine salicylate 1Diphenhydramine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Mastocytosis, Cutaneous × Clear all
NCT04846348 2024-04-25

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Mayo Clinic

Phase 2 Terminated
1 enrolled 7 charts
DermatologicMyeloid

Mastocytosis, Cutaneous

NCT04377828 2020-09-25

LaserMasto

University Hospital, Toulouse

Phase NA Unknown
34 enrolled
DermatologicMyeloid

Mastocytosis, Cutaneous

NCT02441166 2019-07-15

EvaTryMS

University Hospital, Toulouse

Phase NA Completed
250 enrolled
DermatologicMyeloid

Mastocytosis, Cutaneous, Mastocytosis, Systemic

NCT00457288 2007-11-12

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

JADO Technologies GmbH

Phase 2 Completed
30 enrolled
DermatologicMyeloid

Mastocytosis, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡